K. Smalley, N. Haass, P. Brafford, M. Lioni, K. Flaherty et al., Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases, Molecular Cancer Therapeutics, vol.5, issue.5, pp.1136-1180, 2006.
DOI : 10.1158/1535-7163.MCT-06-0084

G. Dimri, X. Lee, and G. Basile, A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.9363-9370, 1995.
DOI : 10.1073/pnas.92.20.9363

C. Gaggioli, G. Robert, and C. Bertolotto, Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway, Journal of Investigative Dermatology, vol.127, issue.2, pp.400-410, 2007.
DOI : 10.1038/sj.jid.5700524

C. Law, K. Chandran, S. Sidorenko, and E. Clark, Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk., Molecular and Cellular Biology, vol.16, issue.4, pp.1305-1320, 1996.
DOI : 10.1128/MCB.16.4.1305

P. Esteve, H. Chin, and S. Pradhan, Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters, Proceedings of the National Academy of Sciences, vol.102, issue.4, pp.1000-1005, 2005.
DOI : 10.1073/pnas.0407729102

N. Baptiste-okoh, A. Barsotti, and C. Prives, Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner, Cell Cycle, vol.7, issue.9, pp.1133-1141, 2008.
DOI : 10.4161/cc.7.9.5805

W. El-deiry, T. Tokino, and V. Velculescu, WAF1, a potential mediator of p53 tumor suppression, Cell, vol.75, issue.4, pp.817-842, 1993.
DOI : 10.1016/0092-8674(93)90500-P

C. Sherr and J. Roberts, CDK inhibitors: positive and negative regulators of G1-phase progression, Genes & Development, vol.13, issue.12, pp.1501-1513, 1999.
DOI : 10.1101/gad.13.12.1501

P. Komarov, E. Komarova, and R. Kondratov, A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy, Science, vol.285, issue.5434, pp.1733-1740, 1999.
DOI : 10.1126/science.285.5434.1733

L. Wang, E. Devarajan, J. He, S. Reddy, and J. Dai, Transcription Repressor Activity of Spleen Tyrosine Kinase Mediates Breast Tumor Suppression, Cancer Research, vol.65, issue.22, pp.10289-97, 2005.
DOI : 10.1158/0008-5472.CAN-05-2231

L. Wang, L. Duke, and P. Zhang, Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer, Cancer Res, vol.63, pp.4724-4754, 2003.

H. Nakashima, S. Natsugoe, and S. Ishigami, Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer, Cancer Letters, vol.236, issue.1, pp.89-94, 2006.
DOI : 10.1016/j.canlet.2005.05.022

F. Zhou, J. Hu, H. Ma, M. Harrison, and R. Geahlen, Nucleocytoplasmic Trafficking of the Syk Protein Tyrosine Kinase, Molecular and Cellular Biology, vol.26, issue.9, pp.3478-91, 2006.
DOI : 10.1128/MCB.26.9.3478-3491.2006

K. Vousden and D. Lane, p53 in health and disease, Nature Reviews Molecular Cell Biology, vol.331, issue.4, pp.275-83, 2007.
DOI : 10.1038/nrm2147

B. Chang, K. Watanabe, and E. Broude, Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases, Proceedings of the National Academy of Sciences, vol.97, issue.8
DOI : 10.1073/pnas.97.8.4291

A. Noda, Y. Ning, S. Venable, O. Pereira-smith, and J. Smith, Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression Screen, Experimental Cell Research, vol.211, issue.1, pp.90-98, 1994.
DOI : 10.1006/excr.1994.1063

S. Cozzi, P. Parsons, S. Ogbourne, J. Pedley, and G. Boyle, Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway, Cancer Research, vol.66, issue.20, pp.10083-91, 2006.
DOI : 10.1158/0008-5472.CAN-06-0348

M. Fogarty, E. Downer, and V. Campbell, A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons, Biochemical Journal, vol.371, issue.3, pp.789-98, 2003.
DOI : 10.1042/bj20021660